Kloock, S.; Haerting, N.; Herzog, G.; Oertel, M.; Geiger, N.; Geier, A.; Sequeira, V.; Nickel, A.; Kohlhaas, M.; Fassnacht, M.;
et al. Effects of NPY-2 Receptor Antagonists, Semaglutide, PYY3-36, and Empagliflozin on Early MASLD in Diet-Induced Obese Rats. Nutrients 2024, 16, 904.
https://doi.org/10.3390/nu16060904
AMA Style
Kloock S, Haerting N, Herzog G, Oertel M, Geiger N, Geier A, Sequeira V, Nickel A, Kohlhaas M, Fassnacht M,
et al. Effects of NPY-2 Receptor Antagonists, Semaglutide, PYY3-36, and Empagliflozin on Early MASLD in Diet-Induced Obese Rats. Nutrients. 2024; 16(6):904.
https://doi.org/10.3390/nu16060904
Chicago/Turabian Style
Kloock, Simon, Niklas Haerting, Gloria Herzog, Marie Oertel, Niklas Geiger, Andreas Geier, Vasco Sequeira, Alexander Nickel, Michael Kohlhaas, Martin Fassnacht,
and et al. 2024. "Effects of NPY-2 Receptor Antagonists, Semaglutide, PYY3-36, and Empagliflozin on Early MASLD in Diet-Induced Obese Rats" Nutrients 16, no. 6: 904.
https://doi.org/10.3390/nu16060904
APA Style
Kloock, S., Haerting, N., Herzog, G., Oertel, M., Geiger, N., Geier, A., Sequeira, V., Nickel, A., Kohlhaas, M., Fassnacht, M., & Dischinger, U.
(2024). Effects of NPY-2 Receptor Antagonists, Semaglutide, PYY3-36, and Empagliflozin on Early MASLD in Diet-Induced Obese Rats. Nutrients, 16(6), 904.
https://doi.org/10.3390/nu16060904
